Applications of Evonik VESTAMID® Care ML17 Medical Grade Nylon 12 in Industrial Manufacturing

Evonik VESTAMID® Care ML17 is engineered for demanding medical and industrial applications where purity, biocompatibility, and process reliability are paramount. The following sections outline key downstream markets in which ML17 is deployed as a critical raw material, each with distinct regulatory, formulation, production, and finished goods requirements.

1. Intravenous Catheter Tubing Production

Medical device manufacturers select VESTAMID® Care ML17 to achieve kink-resistant, biocompatible, and stable performance in IV catheter tubing, fulfilling both processing and patient safety criteria. The polymer meets rigid standards for long-term body contact and supports micro-extrusion processes required for precision lumen geometries. In this scenario, cleanroom manufacturing uses accurate blending to control flexibility, lumen diameter, and flow properties, delivering catheter tubes for varied clinical indications including oncology and intensive care.

Industry compliance standards

• ISO 10993 (Biological Evaluation of Medical Devices)
• USP Class VI (United States Pharmacopeia for plastic materials)
• ISO 13485 QMS (Medical Device Manufacturing)
• 21 CFR 177.1500 (FDA, Polyamide Resins for Food Contact—relevant for parenteral use)

Typical usage ratio

• 90–100% neat ML17 resin, occasionally mixed with 1–5% color concentrate or co-extruded with 5–10% other polyamides to fine-tune mechanical strength or flexibility.

Downstream process integration

• Pellets metered directly into twin-screw medical micro-extruders within Class 7/8 cleanroom environments; resin is typically dried immediately prior to extrusion to ensure consistent melt viscosity and prevent hydrolytic degradation.

Final product types

• Peripheral IV catheter tubes
• PICC lines (peripherally inserted central catheters)
• Midline catheters
• Disposable introducer sheaths

2. Balloon Catheter Shaft Manufacturing

Interventional cardiology and radiology device producers employ ML17 for balloon catheter shafts requiring a precise balance of tensile strength, chemical resistance, and controlled elongation. The polymer's documented biocompatibility and resistance to standard sterilization cycles enable manufacturers to maintain compliance and deliver consistent product performance. Downstream processes emphasize dimensional stability and bondability for multilayer shaft constructions.

Industry compliance standards

• ISO 10993-1 (Evaluation and testing within a risk management process)
• ISO 25539-1/2 (Cardiovascular Implants—Endovascular Devices)
• FDA 21 CFR 820 (Quality System Regulation for finished medical devices)
• REACH, RoHS (Limitation of hazardous substances for European markets)

Typical usage ratio

• 60–95% ML17 by weight in the shaft core or liner; formula adjusted based on required shaft durometer and layer thickness; often co-extruded with 5–40% polyether block amide or fluoropolymer for segmental flexibility, torque, or lubricity enhancement.

Downstream process integration

• Continuous or multilayer extrusion processes, followed by heat-forming and laser or solvent bonding during sub-assembly; compounded ML17 often dry-blended with processing aids to stabilize melt flow and ensure uniform shaft wall distribution in complex geometries.

Final product types

• Coronary and peripheral angioplasty balloon catheters
• Neurovascular micro-catheters
• Steerable ablation catheter shafts
• Radial and femoral access arterial sheaths

3. Medical Device Tubing for Drug Delivery

ML17 finds extensive use in medical tubing designed for pharmaceutical drug delivery systems, where the polymer’s leachables/extractables profile, chemical inertness, and oxygen barrier characteristics support regulatory clearance. Drug delivery device makers use ML17 in precision extrusion for both ambulatory and stationary infusion solutions, focusing specifically on the compatibility with commonly used medications and sterilization protocols.

Industry compliance standards

• USP <87> and <88> (Biological Reactivity Tests)
• FDA 21 CFR 820 (QS System Regulation)
• Ph. Eur. 3.2.2 (Plastic Containers and Closures for Pharmaceutical Use)
• ISO 14971 (Medical Device Risk Management)

Typical usage ratio

• 85–100% ML17, with minor adjustments (up to 10% compatible plasticizer or co-polymer) when tailoring kink resistance or modifying transparency for specific application needs.

Downstream process integration

• Resin granules dried and gravity-fed into high-precision extrusion lines; process incorporates on-line laser dimensional monitoring and extrusion under laminar airflow; post-extrusion, tubing commonly subjected to irradiation or autoclave sterilization.

Final product types

• Infusion pump tubing sets
• Elastomeric pump catheters
• Ambulatory drug delivery line sets
• Multi-lumen tubing for hospital pharmacy compounding systems

4. Respiratory Device Components

Ventilation and respiratory therapy equipment manufacturers rely on ML17 for flexible tubing and connector systems contacting breathing gas, where resistance to repeated sterilization, microbe colonization, and cleaning chemicals is mandatory. These components permit safe, efficient oxygen and air delivery in hospital, emergency, and homecare environments. Downstream operators emphasize maintaining low particulate and total organic carbon levels throughout manufacturing.

Industry compliance standards

• ISO 18562-1 (Biocompatibility evaluation of breathing gas pathways)
• ISO 5367 (Anaesthetic and respiratory equipment—breathing tubes)
• EN ISO 13485 QMS
• FDA 510(k) cleared device requirements

Typical usage ratio

• 95–100% medical grade ML17 per tubing section; up to 5% compatible colorant allowed for connector identification, depending on customer and regulatory requirements.

Downstream process integration

• Direct pellet feed to single or multi-lumen breathing circuit extrusion lines; product cools on air or water-cooled sizing mandrels before cut-to-length operations and automated leak-proof connector assembly; finished goods typically gamma or ETO sterilized.

Final product types

• Ventilator breathing circuits
• Oxygen therapy tubing
• Y-connectors, elbows, and respiratory manifold fittings
• Portable emergency airway adapters

5. Surgical Instrument Handle Overmolding

Precision surgical instrument manufacturers overmold instrument handles with ML17 to achieve a clean, grippable, and repeated-autoclave-resistant surface. The material’s mechanical stability and resistance to hospital disinfectants uphold reliability through frequent reuse cycles. Overmolding integrates with stainless steel or engineered composite instrument cores in automated, closed-mold injection systems, ensuring robust adhesion and ergonomic part shaping to spec.

Industry compliance standards

• ISO 7153-1 (Materials for surgical instruments)
• ISO 10993-5 (Tests for in vitro cytotoxicity)
• FDA 21 CFR 820 (Quality System Regulation)
• ISO 11135/11137 (Sterilization standards for terminally sterilized medical devices)

Typical usage ratio

• 100% ML17 in handle overmold; no blending required for standard application, but can incorporate up to 8% tactile modifiers or pigments for colored or textured ergonomic grips if specified by end use.

Downstream process integration

• Direct injection onto precleaned metal or polymer substrates through multi-cavity tooling; handles formed via hot-runner or cold-runner injection systems, typically in ISO Class 8 cleanrooms; conditioned parts undergo dimensional and mechanical QC prior to assembly and sterilization.

Final product types

• Laparoscopic instrument handles
• Orthopedic screwdrivers
• Surgical scissors, forceps, and clamps
• Biopsy tool grips

6. Inhaler Device Housings and Valves

Producers of metered dose and dry powder inhalers specify ML17 for critical housing, valve, and actuator components requiring high purity, dimensional integrity under pressurized propellants, and proven migration and extractables control. Processing places strong emphasis on injection molding repeatability, maintaining particulate counts below pharmaceutical limits and multi-batch material traceability down to the lot level.

Industry compliance standards

• USP <661.1> (Plastic Materials of Construction)
• Ph. Eur. 3.1.5 (Polyamides for Containers and Closures)
• ISO 13485 (Quality Management for Medical Devices)
• FDA Drug Master File (DMF) referencing for device manufacturers

Typical usage ratio

• 100% ML17 pellets for primary parts; up to 7% mold-release additive for complex geometry housings or up to 10% compatible anti-static concentrate if specified by device MCA dossier (for dry powder actuation components).

Downstream process integration

• High-cavitation precision injection molding, using strictly controlled mold temperatures and cycle timing to prevent warping or flash; post-mold parts handled in controlled environments, deburred and lot coded before device assembly and fill-finish stages.

Final product types

• Metered dose inhaler canister housings
• Dry powder inhaler actuator bodies
• Device valve and gasket seats
• Nasal spray pump assemblies